FDA Offers Advice on Safe Dosing Practices for Diabetes Medications
Friday, July 26th, 2024
The U.S. Food and Drug Administration (FDA) has issued a warning to both patients and healthcare providers regarding dosing errors associated with compounded versions of Novo Nordisk’s weight-loss and diabetes